November 18, 2026
Health news, explained with evidence
LIVE
CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Recall Issued for Generic Propranolol Over Potential Metal Contamination Understanding Food Science: Why Some Leftovers Freeze Better Than Others Could an mRNA Vaccine Help Treat Acne? AI-Generated Hospital Discharge Summaries Outperform Human Versions in Clinical Study FDA Leadership Uncertainty Follows Withdrawal of Commissioner Nominee CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Recall Issued for Generic Propranolol Over Potential Metal Contamination Understanding Food Science: Why Some Leftovers Freeze Better Than Others Could an mRNA Vaccine Help Treat Acne? AI-Generated Hospital Discharge Summaries Outperform Human Versions in Clinical Study FDA Leadership Uncertainty Follows Withdrawal of Commissioner Nominee

Scientists Develop Hybrid Malaria Parasite to Enhance Whole-Parasite Vaccine Efficacy

🔬 Research 2 min read 👁 3

Researchers have bred a hybrid malaria parasite that combines high manufacturing yields with superior liver infectivity, paving the way for next-generation vaccines.

Scientists Develop Hybrid Malaria Parasite to Enhance Whole-Parasite Vaccine Efficacy🔬Research

Photo: Medical Xpress

Key points

  • Hybrid parasite AV27 combines manufacturing yield and high liver infectivity.
  • Created through natural mating in mosquitoes without genetic engineering.
  • Aims to improve next-generation whole-parasite malaria vaccines.

Scientists have successfully bred a hybrid malaria parasite, designated AV27, designed to improve the effectiveness of whole-parasite malaria vaccines. Published in JCI Insight, the study details how researchers combined the strong manufacturing capabilities of a long-standing laboratory strain with the enhanced liver-infectivity traits of a parasite recently gathered in East Africa.

Traditional whole-parasite vaccines rely on a single strain isolated in 1979, which is exceptional for laboratory production but poor at invading human liver cells compared to contemporary circulating strains. By encouraging natural sexual reproduction between strains inside mosquitoes and utilizing modern genomics, the team screened numerous clones without adding or engineering any artificial genes. The resulting hybrid inherits balanced traits from both parent strains, achieving significantly higher liver infection rates while maintaining high production yields in mosquitoes.

Whole-parasite candidates like AV27 are intended to be fully attenuated by deleting specific genes, allowing the parasite to mature inside liver cells without entering the bloodstream where clinical illness begins. While earlier trials of whole-parasite vaccines have demonstrated promising protection, researchers emphasize that this work remains in early developmental stages. Experts remind readers to consult qualified healthcare providers for individual medical advice and vaccination decisions.

What to know:
  • Researchers bred AV27, a hybrid malaria parasite, through selective cross-breeding of two different strains inside mosquitoes.
  • The hybrid matches the high manufacturing yield of older laboratory strains while infecting human liver cells significantly better.
  • The findings support the development of next-generation whole-parasite vaccines, though clinical evaluations are ongoing.

Source Medical Xpress — medicalxpress.com/news/2026-11-scientists-pan-african-malaria-parasite.… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.